Oxford Biomedica plc (OXB.L) LSE

Currency In GBp

AD

Valuation

Market Cap690.56M
Enterprise Value741.8M
P/E Ratio-20.69
PEG Ratio-0.6
Price/Sales Ratio4.24
Price/Book Ratio6.85
Enterprise/Revenue4.54
Enterprise/EBITDA-84.01

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.18
Operating Margin-0.18
AD

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.49

Income Statement

Revenue168.74M
Revenue/Share1.59
Gross Profit65.98M
EBITDA-9.12M
Net Income-30.13M
Diluted EPS-0.27

Balance Sheet

Total Cash96.88M
Total Cash/Share0.92
Total Debt148.13M
Total Debt/Equity1.62
Current Ratio2.2
Book Value Per Share0.86

Price History

52-Week Change92.51
52-Week High962
52-Week Low305.5
Moving Average 50 Days614.96
Moving Average 200 Days648.09

Statistics

Average Volume295,558
Shares Outstanding120.98M
% Held by Institutions2.36

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 30, 2018
AD